DRKS00029226

Evaluation of the penetration of caffeine from caffeine-containing shampoos into the skin and hair follicles

The Procter & Gamble Company, Mason Business CenterDr. Jim Schwartz8700 Mason - Montgomery Road45040 Mason, OHUnited States·Deutsches Register Klinischer StudienRecruitment Completed
Study focus
Disease/Condition
None ;Healthy volunteers
Study type
Interventional
Sponsor & location
Primary sponsor
The Procter & Gamble Company, Mason Business CenterDr. Jim Schwartz8700 Mason - Montgomery Road45040 Mason, OHUnited States
Location
Germany
Timeline & enrollment
Phase
N/A
Start date
N/A
End date
N/A
Summary

The hormone dihydrotestosterone (DHT), of which everyone has more or less on their scalp, is a form of testosterone and is responsible for hair loss. The hereditary hypersensitivity of the hair root to the male hormone testosterone is considered the most common cause of hair loss in men (around 95 percent) and in women (80 percent) (androgenetic hair loss). Caffeine can block this hormone to prevent hair loss and promote hair growth by prolonging the hair growth phase. The depth of penetration into the hair follicle is particularly important for the effect of caffeine. The aim of this study is to deliver an increased amount of caffeine into the infundibulum of the hair to enhance the hair growth promoting effect of caffeine. It will be investigated how caffeine is distributed in the skin and the hair follicle. For this purpose, the individual upper skin layers will be removed using the so-called differential tape stripping method with 50 tears of adhesive tape and then subjected to analysis. Finally, cyanoacrylate is applied to the skin and the hair shaft contents are removed and also examined. For these investigations, three different hair washing products are applied to the calf.

ICD-10 classifications
Healthy person accompanying sick personRoutine general health check-up of armed forcesRoutine general health check-up of sports teamsRoutine general health check-up of inhabitants of institutions
Data source
Registry
Deutsches Register Klinischer Studien
Trial ID
DRKS00029226
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for DRKS00029226 through Pure Global AI's free database. This phase not specified trial is sponsored by The Procter & Gamble Company, Mason Business CenterDr. Jim Schwartz8700 Mason - Montgomery Road45040 Mason, OHUnited States and is currently Recruitment Completed. The study focuses on None ;Healthy volunteers.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Deutsches Register Klinischer Studien data, helping medical device and pharmaceutical companies navigate clinical research efficiently.